Circulating miR-125b expression is reported to correlate with chemoresistace of breast cancer, and importantly, reduction of miR-125b could sensitize breast cancer cell to chemotherapy by targeting E2F3 [63]. The gene discussed is E2F3; the disease is breast cancer.